21 October 2021>: Clinical Research
Integrating Intrinsic Radiosensitivity and Immune Status for Predicting Benefits of Radiotherapy in Head and Neck Squamous Cell Carcinoma
Chuyao Sun 12ADE , Miao Zhang 1BCF , Qiao Qiao 1ADE , Yanli Wang 1C*DOI: 10.12659/MSM.932126
Med Sci Monit 2021; 27:e932126
Table 1 PSM result in RS-immune group.
Matching variables | No RT | RT | P value |
---|---|---|---|
7 | 16 | ||
0.732 | |||
I | 1 | 1 | |
II | 5 | 11 | |
III | 1 | 4 | |
0.718 | |||
I | 0 | 1 | |
III | 2 | 3 | |
IV | 5 | 12 | |
0.657 | |||
No | 4 | 11 | |
Yes | 3 | 5 | |
1.000 | |||
Negative | 6 | 12 | |
Positive\close | 1 | 4 | |
0.621 | |||
No | 6 | 11 | |
Micro-invasion\gross invasion | 1 | 5 | |
0.371 | |||
No | 5 | 7 | |
Yes | 2 | 9 | |
– | |||
No | 7 | 16 | |
Yes | 0 | 0 | |
PSM – propensity score matching; RS – radiosensitive. |